Brainstorm issues 2020 letter to shareholders

New york, dec. 28, 2020 /prnewswire/ -- brainstorm cell therapeutics inc. (nasdaq: bcli), a leading developer of cellular therapies for neurodegenerative diseases, today announced the following letter from its chief executive officer, chaim lebovits, to its shareholders and the investment...
BCLI Ratings Summary
BCLI Quant Ranking